VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26344154)

Published in Ann Ital Chir on September 08, 2015

Authors

Nikolaos Kostakopoulos, Vassilis Protogerou, Andreas Skolarikos, Ioannis Varkarakis, Athanasios Papatsoris, Theodore Troupis, Maria Piagou, Charalambos Deliveliotis

Articles by these authors

Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study. Eur Urol (2007) 2.49

Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int (2011) 2.26

Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience. Eur Urol (2007) 2.15

Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int (2013) 2.07

Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome. J Urol (2004) 1.70

Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology (2004) 1.59

Percutaneous nephrolithotomy in horseshoe kidneys: factors affecting stone-free rate. J Urol (2011) 1.57

Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol (2012) 1.56

Long-term survival analysis after laparoscopic radical nephrectomy. J Urol (2005) 1.50

Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences? Urology (2012) 1.49

Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol (2013) 1.45

Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int J Urol (2011) 1.44

Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology (2006) 1.43

Primary small cell bladder carcinoma: a case report and review of the current literature. Tumori (2007) 1.42

Bladder lithiasis: from open surgery to lithotripsy. Urol Res (2006) 1.39

Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol (2011) 1.27

Horseshoe kidney: a review of anatomy and pathology. Surg Radiol Anat (2013) 1.24

Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med (2008) 1.16

Modified ileal neobladder for continent urinary diversion: functional results after 9 years of experience. J Urol (2004) 1.16

Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence? J Urol (2005) 1.13

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group. Urology (2004) 1.12

Ultrasound-guided percutaneous nephrostomy performed by urologists: 10-year experience. Urology (2006) 1.10

The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy. Anticancer Res (2006) 1.07

Percutaneous endourologic procedures in high-risk patients in the lateral decubitus position under regional anesthesia. J Endourol (2009) 1.06

Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol (2005) 1.05

Is there still a role for open surgery in the management of renal stones? Curr Opin Urol (2006) 1.05

Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol (2008) 1.04

Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol. AJR Am J Roentgenol (2007) 1.03

Nerve sparing radical prostatectomy: effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model. J Urol (2004) 1.03

Incontinence and erectile dysfunction following radical prostatectomy: a review. ScientificWorldJournal (2005) 1.00

Penile fractures: immediate surgical approach with a midline ventral incision. BJU Int (2009) 1.00

Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol (2011) 0.99

An anatomical study of the pterygospinous and pterygoalar bars and foramina - their clinical relevance. J Craniomaxillofac Surg (2008) 0.99

Short- and long-term complications of open radical prostatectomy according to the Clavien classification system. BJU Int (2008) 0.98

Pseudosarcomatous myofibroblastic lesion of the urinary bladder: a rare entity posing a diagnostic challenge and therapeutic dilemma. Diagn Pathol (2008) 0.97

Tissue-engineered vascularized bone grafts: basic science and clinical relevance to trauma and reconstructive microsurgery. Microsurgery (2011) 0.97

Complications of abdominal urologic laparoscopy: longitudinal five-year analysis. Urology (2004) 0.95

Lingual and facial arteries arising from the external carotid artery in a common trunk. Am Surg (2011) 0.92

Current status of ureteroscopic treatment for urolithiasis. Int J Urol (2009) 0.92

Colon perforation during percutaneous renal surgery: a 10-year experience in a single endourology centre. Urol Res (2012) 0.91

Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer. Urology (2011) 0.91

Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens) (2009) 0.90

Inflammatory Myofibroblastic Bladder Tumor in a Patient with Von Recklinghausen's Syndrome. Case Rep Med (2010) 0.89

Anatomical variation and morphology in the position of the palatine foramina in adult human skulls from Greece. J Craniomaxillofac Surg (2011) 0.89

Manipulation of the nerve growth factor network in prostate cancer. Expert Opin Investig Drugs (2007) 0.87

Greenlight laser in benign prostatic hyperplasia: turning green into gold. Curr Opin Urol (2008) 0.87

Use of external ureteral catheters and internal double J stents in a modified ileal neobladder for continent diversion: a comparative analysis. Urol Int (2005) 0.87

Molecular pathogenetics of renal cancer. Am J Nephrol (2006) 0.87

Modified S-pouch neobladder vs ileal conduit and a matched control population: a quality-of-life survey. BJU Int (2004) 0.87

Problems faced by relatives caring for cancer patients at home. Int J Nurs Pract (2009) 0.86

Does educational printed material manage to change compliance with prostate cancer screening? World J Urol (2008) 0.86

Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol (2012) 0.86

Extracorporeal shock wave lithotripsy produces a lower stone-free rate in patients with stones and renal cysts. Int J Urol (2002) 0.85

Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. Oncology (2008) 0.85

An overview of stress urinary incontinence treatment in women. Aging Clin Exp Res (2007) 0.84

Ureteroscopic removal of mildly migrated stents using local anesthesia only. J Urol (2007) 0.84

The pterygopalatine ganglion and its role in various pain syndromes: from anatomy to clinical practice. Pain Pract (2011) 0.84

Solitary neurofibroma of the spermatic cord. Int Urol Nephrol (2002) 0.84

Ureteric guidewire damage by Holmium:YAG laser: preliminary results. Urol Res (2009) 0.84

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model. BMC Cancer (2010) 0.84

Effect of simple malrotation on percutaneous nephrolithotomy: a matched pair multicenter analysis. J Urol (2011) 0.84

Upper urinary tract transitional cell carcinoma. A 10-year experience. Tumori (2008) 0.83

Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation. Urology (2006) 0.83

The current role of percutaneous chemolysis in the management of urolithiasis: review and results. Urolithiasis (2013) 0.83

To biopsy a small renal mass, or not? Nephrourol Mon (2012) 0.83

Unreliable residual volume measurement after increased water load diuresis. Int J Urol (2004) 0.82

Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival. Anticancer Res (2011) 0.82

Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer. Urol Int (2011) 0.82

Splenogonadal fusion: report of a case and review of the literature. Int J Urol (2005) 0.82

Indications, prediction of success and methods to improve outcome of shock wave lithotripsy of renal and upper ureteral calculi. Arch Ital Urol Androl (2010) 0.81

Local steroid application during nerve-sparing radical retropubic prostatectomy. BJU Int (2005) 0.81

Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder. Urology (2005) 0.80

Pathological review of internal genitalia after anterior exenteration for bladder cancer in women. Evaluating risk factors for female organ involvement. Int Urol Nephrol (2007) 0.80

Androgen deprivation therapy and cardiovascular risk. Nephrourol Mon (2012) 0.79

Multifocality of renal cell tumors is a factor to consider before performing a partial nephrectomy. Anticancer Res (2003) 0.79

Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy. J Cancer Res Clin Oncol (2009) 0.79

Management of JJ stent-related symptoms. Acta Chir Iugosl (2014) 0.79

Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU Int (2014) 0.79

Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study. Urology (2004) 0.79

'An interventional urology list' - a novel concept for UK urological services. Ann R Coll Surg Engl (2010) 0.79

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group. Anticancer Drugs (2016) 0.79

Laparoscopic transposition of lower-pole crossing vessels in the management of pelvi-ureteric junction obstruction. BJU Int (2008) 0.78

Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC). Expert Opin Pharmacother (2009) 0.78